MyFinsight
Home
Blog
About
Contact
Download
Download image
Integrated Service Program
$1,121,134
(74.30%↑ Y/Y)
Allergy Diagnostic Kit
Sales
$823,108
(-1.19%↓ Y/Y)
Immunotherapy Treatment Sales
$487,762
(19.16%↑ Y/Y)
Clinical Study Revenue
$133,650
(0.00%↑ Y/Y)
Subscription Revenue
$43,731
(-19.79%↓ Y/Y)
Shipping And Handling
$41,670
(16.10%↑ Y/Y)
Training And Other
Revenue
$40,686
(82.09%↑ Y/Y)
Revenue
$2,691,741
(26.26%↑ Y/Y)
Gross profit
$1,810,849
(33.36%↑ Y/Y)
Cost of revenue
$880,892
(13.81%↑ Y/Y)
Gain on
extinguishment of debt, net
$665,755
Net operating
income
$131,244
(-36.21%↓ Y/Y)
Other income
$82
(5.13%↑ Y/Y)
Total operating
expenses
$1,679,605
(45.78%↑ Y/Y)
Income (loss) before
income taxes
$457,417
(276.45%↑ Y/Y)
Interest expense
$237,413
(-48.95%↓ Y/Y)
Loss on conversion of
debt
$102,251
Sales and marketing
$683,477
(34.26%↑ Y/Y)
Research and development
$484,873
(64.65%↑ Y/Y)
General and
administrative
$439,143
(58.82%↑ Y/Y)
Amortization
$72,112
(0.00%↑ Y/Y)
Net income (loss)
$457,417
(276.45%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
QHSLab, Inc. (USAQ)
QHSLab, Inc. (USAQ)